Ensuring Adventitious Agent Safety in Biologics

Creating effective strategies to mitigate risk and enable prompt remediation of viral, prion and mycoplasma contamination

17 19 October 2011

14 speakers

  • Jens-Peter Gregersen @novartis SME Virology, Virus Safety, New Projects R&D, Novartis Vaccines and Diagnostics
  • Thomas R. Kreil, PhD @baxter_intl Associate Professor of Virology Senior Director Viral Vaccines & Global Pathogen Safety Baxter BioScience
  • Emiliano Toso @MerckSerono_de Molecular Biology Lab Head, Merck Serono
  • Sebastien Carayol @sanofipasteur Manager of Scientific Bioprocess R&D, Downstream Process, Sanofi Pasteur
  • Marc Martin Viral Safety Assessor, AFSS APS
  • Walter De Matteo Microbiological Laboratory Manager, Quality Control, IBSA Institut Biochimique SA
  • Hans Nitschko Doctor of Diagnostic Virology, Max von Pettenkofer Institute, University of Munich
  • Barbara Potts Senior Consultant, Potts and Nelson Consulting, LL C, Chair, Mycoplasma Task Force, PDA
  • Tanja Opriessnig Associate Professor, Department of Veterinary Diagnostic and Production Animal Medicine, Veterinary Diagnostic Laboratory - Iowa

14 known attendees

  • Pharmaceutical News
  • Veronica Araujo
  • Rachel Yaroschuk
  • CSL Behring
  • Roche
  • Genzyme Corporation
  • kaitlen
  • AdventAgentSafety
  • Jana Köller
  • Eli Lilly & Company
  • Novartis
  • Baxter International
  • Merck Serono DE
  • Sanofi Pasteur

Tell your friends!

Share this event with your friends on Twitter

Topics

Share

Coverage

1 slide deck

Added 5 years ago

1 audio clip

Added 5 years ago

2 write-ups

Most recent added 5 years ago

2 handouts

Most recent added 5 years ago

See all coverage

6 items in total

Staff


Call for participation

Related books

  • Wonders of Life
  • Big Blue Ocean

See something wrong?

Report an issue with this event